Additionally, in stroke patients, high Gal-3 concentrations have been significantly associated with death or disability at three months in a cohort of 3082 patients, reinforcing its relevance as a prognostic biomarker in cerebrovascular events [102]. This evidence concerns the gene LGALS3 and stroke disorder.